Insight Molecular Diagnostics, Inc. (IMDX)
5.85
+0.13
(+2.27%)
USD |
NASDAQ |
Jun 09, 16:00
5.83
-0.02
(-0.34%)
After-Hours: 20:00
Insight Molecular Diagnostics Total Assets (Quarterly) : 40.43M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Precigen, Inc. | 138.63M |
| Agenus, Inc. | 186.46M |
| Amgen, Inc. | 92.50B |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| Imunon, Inc. | 8.019M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.12M |
| Shareholders Equity (Quarterly) | -10.69M |
| Debt to Equity Ratio | -0.2871 |
| Current Ratio | 2.542 |
| Net Debt Paydown Yield | 0.11% |